Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Current Taxes: 2010-2024

Historic Current Taxes for China Pharma Holdings (CPHI) over the last 5 years, with Dec 2024 value amounting to $595,476.

  • China Pharma Holdings' Current Taxes rose 73.26% to $691,677 in Q3 2025 from the same period last year, while for Sep 2025 it was $691,677, marking a year-over-year increase of 73.26%. This contributed to the annual value of $595,476 for FY2024, which is 42.03% down from last year.
  • According to the latest figures from FY2024, China Pharma Holdings' Current Taxes is $595,476, which was down 42.03% from $1.0 million recorded in FY2023.
  • China Pharma Holdings' 5-year Current Taxes high stood at $1.0 million for FY2023, and its period low was $595,476 during FY2024.
  • For the 2-year period, China Pharma Holdings' Current Taxes averaged around $811,331, with its median value being $811,331 (2023).
  • Data for China Pharma Holdings' Current Taxes shows a maximum YoY crashed of 42.03% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows China Pharma Holdings' Current Taxes stood at $1.0 million in 2023, then tumbled by 42.03% to $595,476 in 2024.